story of the week
Survival Outcomes in Patients With HR+ MBC With Low or No HER2 Expression Treated With Targeted Therapies Plus Endocrine Therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA Network Open
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Survival Outcomes in Patients With Hormone Receptor-Positive Metastatic Breast Cancer With Low or No ERBB2 Expression Treated With Targeted Therapies Plus Endocrine Therapy
JAMA Netw Open 2023 May 01;6(5)e2313017, JA Mouabbi, A Singareeka Raghavendra, RL Bassett, A Hassan, D Tripathy, RM LaymanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.